Israel Active

Some 1.2 million Israelis have now had a third coronavirus vaccination and wider rollout is imminent. Maccabi Healthcare Services reported 37 (all non-serious) infections in Israelis over 60 who have been triple-vaccinated, compared to 1,064 (many serious) for those who have had only two doses.

Professor Eli Schwartz of Israel’s Sheba Medical Center was unable to publish the results of his successful double-blind trial of ivermectin on 89 coronavirus patients. Interesting reading.

Israel’s SciSparc to commence a Phase 2a clinical trial of its SCI-110 (formerly THX-110) treatment for patients with Alzheimer's disease (AD) and agitation. The study will be conducted at the Israeli Medical Center for Alzheimer's.

Israel’s Nextage Therapeutics is developing technology to deliver to the brain tiny quantities of controversial chemicals, to treat depression and other neurological disorders.

Scientists from Israel’s Weizmann Institute and the Hebrew University of Jerusalem have unveiled how 3-dimensional space is represented in the brain’s “GPS” system. They mapped out how “grid cells” work in bats and the findings have turned the previous theory “on its head”.

The reason the elderly are vulnerable to Covid, is their immune systems fail to recognize a new virus. Scientists at Israel’s Technion Institute, Sourasky (Ichilov) and Rambam hospitals have demonstrated that removing most of the memory B lymphocytes rejuvenates these immune cells.

Israel’s Binah.ai (see previously) is in the final stage of validating its iPhone blood pressure functionality at Israel’s Sheba medical center. The technology records video at up to 120 frames per second, to analyze skin color changes for monitoring vital signs.

Verily Life Sciences, an independent subsidiary of Google's parent company Alphabet, is establishing a Research and Development center in Israel.  The company focuses on digital health, applying AI to medical problems. In Israel it will target colorectal (colon) cancer.

Israel’s Circles has developed a platform designed to help users overcome life’s challenges. It matches groups of 6-8 people who are facing similar difficulties such as divorce, grief, or medical diagnoses, and connects them together for one-hour video meetings. People don’t have to face their struggles alone.

Researchers at Israel’s Beilinson Medical Center have found that twice as many organ transplant recipients developed antibodies after their 3rd anti-covid jab compared to their 2nd dose. There were also good results in the over-60s, of which over 750,000 have had their 3rd vaccination.